Study of REGN1400 Alone and in Combination With Erlotinib or Cetuximab in Patients With Certain Types of Cancer
Clinical trial NCT01727869 · COMPLETED
Trial details
- NCT number
- NCT01727869
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-01
- Primary completion
- 2015-01-01
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.